Heparin

serpin family E member 1 ; Homo sapiens







51 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27252904 Comparison of the Effects of Subcutaneous Versus Continuous Infusion of Heparin on Key Inflammatory Parameters Following Sepsis. 2016 Apr 2
2 25966765 Coagulation, Fibrinolysis and Inhibitors in Failing Filters during Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: Effect of Anticoagulation Modalities. 2015 2
3 24473387 [Changes of plasminogen activator inhibitor-1 and D-dimer during continuous blood purification and related factors]. 2014 Jan 4
4 24485402 Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene. 2014 Mar 1
5 23022759 Perioperative PAI-1 values in surgically treated colorectal carcinoma patients under low molecular weight heparin thromboprophylaxis. 2012 Aug 1
6 21829057 [Changes in parameters of coagulation system after treatment of chronic heart failure with β-adrenoblockers, angiotensin-converting enzyme inhibitors, calcium antagonists, diuretics, anticoagulants, antiagregants, cardiac glycosides, and physical exercise]. 2011 1
7 17895513 Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study. 2009 Feb 2
8 19284310 Antimetastatic potential of PAI-1-specific RNA aptamers. 2009 Jun 1
9 19500510 [Effects of serum of patients with MODS on TF and PAI-1 secretion of human vascular endothelial cells during CRRT]. 2009 Jun 1
10 19664058 High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease. 2009 Sep 3
11 16601834 Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin. 2006 Apr 8
12 15607575 De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndrome. 2005 1
13 12891293 [Non ST elevation acute coronary syndrome. Parameters of fibrinolysis during short term use of ticlopidine or clopidogrel]. 2003 1
14 14563580 Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase: comparison with unfractionated heparin. 2003 Oct 15 2
15 14585904 Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. 2003 Nov 1
16 11991242 Effects of a low molecular weight heparin, bemiparin, and unfractionated heparin on hemostatic properties of endothelium. 2002 Jan 1
17 12688145 [Metabolic changes caused by artificial ischemia in knee arthroscopy]. 2002 1
18 11113116 A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product. 2001 Mar 16 1
19 12577350 [Clinical observation on effect of intervention therapy with anticoagulant in treating patients of hypertension complicated with acute ischemic cerebrovascular disease]. 2001 Apr 1
20 10326760 Evidence that heparin but not hirudin reduces PAI-1 expression in cultured human endothelial cells. 1999 May 1 4
21 10545182 Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors. 1999 Nov 2 1
22 10726041 Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndrome. 1999 Oct 1
23 9497365 Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein. 1998 Mar 13 1
24 21235930 Beyond fibrinolysis: the role of plasminogen activator inhibitor-1 and vitronectin in vascular wound healing. 1998 May 1
25 9164872 Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC). 1997 May 15 1
26 9202242 Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I. 1997 Jul 1
27 8702896 Biochemical and biophysical studies of reactive center cleaved plasminogen activator inhibitor type 1. The distance between P3 and P1' determined by donor-donor fluorescence energy transfer. 1996 Aug 30 1
28 8980646 The inhibition of human factor Xa by plasminogen activator inhibitor type 1 in the presence of calcium ion, and its enhancement by heparin and vitronectin. 1996 Dec 5 1
29 7578276 Oversulfated fucoidan and heparin suppress endotoxin induction of plasminogen activator inhibitor-1 in cultured human endothelial cells: their possible mechanism of action. 1995 Oct 19 3
30 7807964 Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells. 1994 Dec 5
31 7947934 Heparin and heparan sulfate enhancement of the inhibitory activity of plasminogen activator inhibitor type 1 toward urokinase type plasminogen activator. 1994 Nov 11 5
32 7950376 Separation of active and inactive forms of recombinant human plasminogen activator inhibitor type 1 (PAI-1) expressed in Chinese hamster ovary cells: comparison with native human PAI-1. 1994 Aug 1
33 8013675 Thrombosis and intrinsic fibrinolysis in percutaneous transluminal angioplasty. 1994 May 1
34 8049432 Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin. 1994 Aug 15 14
35 8172858 Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells. 1994 May 1
36 7506041 Purification and characterization of the plasminogen activator inhibitors PAI-1, PAI-2, and PN-1 from the human glioblastoma U138. 1993 May-Jun 2
37 8121125 [Unstable angina: tissue-type plasminogen activator inhibitor and other hemostatic factors in aspirin and intravenous heparin administration]. 1993 1
38 8431448 Specific glycosaminoglycans support the inhibition of thrombin by plasminogen activator inhibitor 1. 1993 Feb 16 2
39 1376317 Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation. 1992 Jun 15 1
40 1520875 Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells. 1992 Sep 15 3
41 1661447 Standard heparin but not LMW heparin induces a concomitant increase of t-PA and PAI-1 without modification of global fibrinolysis: study after 60 days treatment. 1991 Sep 1 1
42 1703436 Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin. 1991 Jan 29 11
43 1708387 The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a). 1991 Apr 25 1
44 1715220 On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site. 1991 Sep 1 1
45 1698787 Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. 1990 Oct 25 1
46 1966669 The effect of heparin and other glycosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells. 1990 Jun 1
47 2128972 Heparin stimulates fibrinolysis in mesothelial cells by selective induction of tissue-plasminogen activator but not plasminogen activator inhibitor-1 synthesis. 1990 Nov 30 1
48 2505842 Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C. 1989 Jul 11 1
49 2508260 Additive effect of dDAVP and standard heparin in increasing plasma t-PA. 1989 Jun 30 1
50 2799763 Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells. 1989 Jun 30 4